Tag: CMC
Antibody Drug Conjugate Development: Keys to Rapid IND Submission and Approval
Antibody drug conjugates (ADCs) are a relatively new type of drug that combines the targeting ability of a biologic with a highly potent cytotoxic...
Andrew Huang: “ADC’s Are Among the most Powerful Options to...
With a population of 1.4 billion and a rapidly expanding economy, China has become a manufacturing powerhouse. In addition, China is pursuing a...
Evolving CMC Analytical Techniques for Biopharmaceuticals
1.0 Abstract During the (early) preclinical drug development process as well as manufacturing of biopharmaceutical (protein) products, analysis and characterization are crucial in gaining a...
What the Experts Teach: PepTalk 2015
This year Cambridge Healthtech Institute's 14th Annual PepTalk, the Protein Science Week, being held in San Diego, California January 19 - 23, 2015, welcomed...
